title: Epidermal stem cells are defined by global histone modifications that are altered by Myc-induced differentiation.
abstract: Activation of Myc induces epidermal stem cells to exit their niche and differentiate into sebocytes and interfollicular epidermis, a process that is associated with widespread changes in gene transcription. We have identified chromatin modifications that are characteristic of epidermal stem cells and investigated the effects of Myc activation. Quiescent stem cells in the interfollicular epidermis and the hair follicle bulge had high levels of tri-methylated histone H3 at lysine 9 and H4 at lysine 20. Chromatin in both stem cell populations was hypoacteylated at histone H4 and lacked mono-methylation of histone H4 at lysine 20. Myc-induced exit from the stem cell niche correlated with increased acetylation at histone H4 and transiently increased mono-methylation at lysine 20. The latter was replaced by epigenetic modifications that are largely associated with chromatin silencing: di-methylation at histone H3 lysine 9 and histone H4 lysine 20. These modifications correlated with changes in the specific histone methyltransferases Set8 and Ash-1. The Myc-induced switch from mono- to di-methylated H4K20 required HDAC activity and was blocked by the HDAC inhibitor trichostatin A (TSA). TSA treatment induced a similar epidermal phenotype to activation of Myc, and activation of Myc in the presence of TSA resulted in massive stimulation of terminal differentiation. We conclude that Myc-induced chromatin modifications play a major role in Myc-induced exit from the stem cell compartment.
authors: Wellcome Trust Centre for Stem Cell Research, University of Cambridge, Cambridge, United Kingdom.
authors: Michaela
authors: M
authors: Frye
authors: Amanda G
authors: AG
authors: Fisher
authors: Fiona M
authors: FM
authors: Watt
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000502:physiology*; D049109:Cell Proliferation; D002478:Cells, Cultured; D000078404:Epidermal Cells; D018859:Hair Follicle / Q000166:cytology / Q000502:physiology; D056572:Histone Deacetylase Inhibitors / Q000494:pharmacology; D006655:Histone Deacetylases / Q000235:genetics / Q000378:metabolism; D006657:Histones / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D015603:Keratinocytes / Q000166:cytology / Q000378:metabolism; D008239:Lysine / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics / Q000378:metabolism*; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects / Q000502:physiology*
chemical_list: D056572:Histone Deacetylase Inhibitors; D006657:Histones; D006877:Hydroxamic Acids; D016271:Proto-Oncogene Proteins c-myc; C012589:trichostatin A; D006655:Histone Deacetylases; D008239:Lysine
references: Nat Rev Cancer. 2006 Nov;6(11):846-56
references: 17060944
references: Curr Opin Genet Dev. 2006 Oct;16(5):518-24
references: 16919447
references: J Cell Biol. 2006 Jan 2;172(1):139-49
references: 16391002
references: Drug Discov Today. 2006 Feb;11(3-4):91-3
references: 16533705
references: Ernst Schering Res Found Workshop. 2006;(57):1-27
references: 16568946
references: J Biol Chem. 2006 May 5;281(18):12760-6
references: 16517599
references: Curr Biol. 2006 May 23;16(10):971-81
references: 16713953
references: J Invest Dermatol. 2006 Jul;126(7):1459-68
references: 16778814
references: EMBO J. 2006 Jun 21;25(12):2723-34
references: 16724113
references: Mol Cell Biol. 2000 Jan;20(2):556-62
references: 10611234
references: Curr Biol. 2001 Apr 17;11(8):558-68
references: 11369200
references: Nat Genet. 2001 Jun;28(2):165-8
references: 11381265
references: Science. 2001 Aug 10;293(5532):1074-80
references: 11498575
references: Genes Dev. 2001 Aug 15;15(16):2069-82
references: 11511539
references: Curr Biol. 2002 Jul 9;12(13):1086-99
references: 12121615
references: Nature. 2002 Oct 24;419(6909):857-62
references: 12397363
references: Genes Dev. 2003 May 1;17(9):1115-29
references: 12695333
references: Development. 2003 Jun;130(12):2793-808
references: 12736221
references: EMBO Rep. 2003 Jun;4(6):575-80
references: 12776177
references: Nat Rev Cancer. 2003 Jun;3(6):444-51
references: 12778134
references: Development. 2003 Nov;130(21):5241-55
references: 12954714
references: Development. 2003 Dec;130(24):6049-63
references: 14573520
references: Nat Rev Cancer. 2004 Jul;4(7):562-8
references: 15229481
references: Genes Dev. 2004 Oct 1;18(19):2315-35
references: 15466484
references: J Dent Res. 1981 Aug;60 Spec No C:1611-20
references: 6943171
references: Nucleic Acids Res. 1990 Feb 25;18(4):1068
references: 2156225
references: J Biol Chem. 1990 Oct 5;265(28):17174-9
references: 2211619
references: Blood. 1993 May 1;81(9):2272-82
references: 7683214
references: EMBO J. 1995 Aug 15;14(16):3946-57
references: 7664735
references: Genes Dev. 1997 Nov 1;11(21):2869-82
references: 9353256
references: Development. 1999 Jun;126(11):2409-18
references: 10226000
references: EMBO J. 2004 Nov 10;23(22):4462-72
references: 15510223
references: Genes Dev. 2005 Jun 15;19(12):1444-54
references: 15933069
references: Exp Cell Res. 2005 Nov 1;310(2):344-56
references: 16182285
references: Curr Opin Cell Biol. 2005 Dec;17(6):664-71
references: 16226449
references: J Biol Chem. 2005 Nov 18;280(46):38814-22
references: 16166085
references: Science. 2005 Dec 2;310(5753):1487-9
references: 16322456
references: Dev Cell. 2005 Dec;9(6):855-61
references: 16326396
references: Nat Med. 2005 Dec;11(12):1351-4
references: 16288281
references: Nat Cell Biol. 2006 Jul;8(7):764-70
references: 16767079
references: Semin Cancer Biol. 2006 Aug;16(4):253-64
references: 16904903
references: Semin Cancer Biol. 2006 Aug;16(4):242-52
references: 16935524
references: Curr Opin Genet Dev. 2006 Oct;16(5):502-7
references: 16844365
references: J Invest Dermatol. 2007 May;127(5):1126-39
references: 17195011